BETAXOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Betaxolol, and when can generic versions of Betaxolol launch?
Betaxolol is a drug marketed by Acella, Akorn, Apotex Inc, Medimetriks Pharms, Epic Pharma, and Kvk Tech. and is included in six NDAs.
The generic ingredient in BETAXOLOL is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Betaxolol
A generic version of BETAXOLOL was approved as betaxolol hydrochloride by EPIC PHARMA on October 22nd, 1999.
Summary for BETAXOLOL
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BETAXOLOL |
DailyMed Link: | BETAXOLOL at DailyMed |